A Better Work Environment for Our Team! At Neuro-Sys, we believe that a comfortable and cutting-edge workspace boosts productivity and creativity. Our new facilities offer modern amenities and collaborative spaces, ensuring that our team thrives while they are conducting groundbreaking research on neurodegenerative diseases. Exciting times ahead for our talented professionals! #EmployeeWellbeing #TeamSuccess
NEURO-SYS
Recherche en biotechnologie
Gardanne, BDR 2 892 abonnés
CNS/PNS - In vitro - In vivo - Drug Development
À propos
Neuro-Sys is a research-intensive and innovative organisation specialising in pharmacology and in advanced in vitro and in vivo models of neurodegenerative diseases, mode of action research, and drug development in the CNS and PNS fields. We provide pharmacological profiles of lead compounds and explore their underlying mechanism of action and studies to determine the neuroprotective activity. We’re dedicated to providing high-level technical expertise in a collaborative relationship with our clients and accompany you along the drug development stages, from preclinical to clinical. Our expertise: › Alzheimer’s disease (AD) › Parkinson’s disease (PD) › Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig’s disease) › Multiple Sclerosis (MS) › Peripheral Neuropathies › Blood Brain Barrier DRUG DEVELOPMENT SERVICES Our experts in drug and pharmaceutical development provide expert guidance on: •The design of your drug discovery development plan (pre-clinical testing in vitro and in vivo models) •The design of your preclinical research programs (in vitro/ in vivo, mode of action) •The preclinical (Pharmacology, PK and ADME) development and early clinical designs (PoC studies) •The writing of research projects, investigator brochures (IB), IMPD, ODD submission (FDA/EMA) in neuro indication
- Site web
-
http://www.neuro-sys.com
Lien externe pour NEURO-SYS
- Secteur
- Recherche en biotechnologie
- Taille de l’entreprise
- 11-50 employés
- Siège social
- Gardanne, BDR
- Type
- Partenariat
- Fondée en
- 2013
Lieux
-
Principal
410 Chemin Departemental 60
13120 Gardanne, BDR, FR
-
50 Milk St, 16th floor
02109 BOSTON, MA, US
Employés chez NEURO-SYS
Nouvelles
-
🔬 A new era begins for our clients! With our expansive new facilities, we’re ready to undertake more projects and manage larger, more complex studies. Are you ready to experience the benefits of even higher-quality studies? Drop us a message to get started! #NeuroscienceResearch #Innovation
-
🚀 Big news at NEURO-SYS! We are thrilled to announce that we are moving to new labs, 4 times larger! This will allow us to welcome new talent and increase capacity to conduct neurodegenerative diseases studies. Stay tuned for more details! #Neuro-Sys #Expansion #Neuroscience
-
#SfN24 is just around the corner, and NEURO-SYS will be there showcasing our latest scientific innovations! Come by booth 535 to connect, collaborate, and explore our newest in vitro and in vivo models and research services. And, don't miss the chance to catch one of our posters showcasing our latest findings in Alzheimer's Disease and ALS. PSTR332.06/C62 Tuesday, 10/8/24 1:00pm Impaired proteasome activity and autophagy-lysosome pathway exacerbates motor neuron loss and TDP43 proteinopathy in in vitro models of Amyotrophic Lateral Sclerosis. PSTR389.22/C10 Wednesday, 10/9/24 8:00am Glial and microglial phenotypic changes after treatment with Lecanemab: vitro and vivo evidences.
-
Congratulations to Sasha Milton from University of California, San Francisco who scored Phillies vs. Yankees tickets as part of NEURO-SYS’ #AAIC24 giveaway! We hope that you enjoy the game and have an unforgettable experience at Citizens Bank Park. Special thanks to everyone who participated and helped make our giveaway a success. Stay tuned for more exciting events and opportunities from NEURO-SYS (we hear our #SFN giveaway is 🔥).
-
Presentation day at #AAIC24! Drop by poster # 829 and chat with our CSO, Noelle Callizot on our findings "Lecanemab induces phenotypic change in glial and microglial cells in Alzheimer’s disease models: vitro and vivo evidences." See you there!
-
NEURO-SYS takes part in BIO US in San Diego from June 3 to 6, 2024. It's a great opportunity to meet us for interesting and fruitful collaborations. https://lnkd.in/dKrXuHVa
-
NEURO-SYS is program partner at the 3rd annual ALS Drug Development Summit in Boston, May 21-23, 2024. Alexandre Henriques, our Director of Pharmacology and ALS expert, will be attend. Take the opportunity to discuss science and your ALS R&D projects with him. He will be supported by Lauren Currie, PhD MBA, our VP of Business Development. https://lnkd.in/gCHds7tt Not able to attend the summit, but interested in learning more? Contact us at [email protected]! #ALS